Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > S&P Biotech Index Up 6.2% This Week

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on Nov 05, 2021 11:37am

109 Views

Post# 34092183

RE:RE:S&P Biotech Index Up 6.2% This Week

CYDY is down 80% this year and THTX is up 40%, so this too is a bad take. But I would not mind having CYDY's current market cap!

longterm56 wrote: The sad truth is that the market is treating us like CYDY ... they also post news with no reaction. I'm not saying we are anything like them, just that the market is treating us similarly. Very sad -LT

SPCEO1 wrote: THTX up 0.3%. That is obviously not good. Hopefully, a new communications effort by new staff will sort out how to get THTX on the biotech radar so that it participates in moves like this in the future. Right now, however, it is a backwater biotech stock that gets no respect.